Alkermes plc (NASDAQ:ALKS): A Fundamentally Weighted Stock for Long-Term Investors
Alkermes plc (NASDAQ:ALKS) shares fell to a low of $24.36 before closing at $24.42. Intraday shares traded counted 2.55 million, which was -55.32% lower than
Alkermes plc (NASDAQ:ALKS) shares fell to a low of $24.36 before closing at $24.42. Intraday shares traded counted 2.55 million, which was -55.32% lower than
Alkermes plc (NASDAQ:ALKS) shares fell to a low of $24.9601 before closing at $25.03. Intraday shares traded counted 1.55 million, which was 3.46% higher than
Alkermes plc (NASDAQ:ALKS) shares fell to a low of $23.17 before closing at $24.48. Intraday shares traded counted 2.18 million, which was -37.67% lower than
Alkermes plc (NASDAQ:ALKS) shares traded higher over the last trading session, gaining 0.65% on 06/02/21. The shares fell to a low of $23.11 before closing
Alkermes Plc [NASDAQ: ALKS] stock rose significantly on Monday after the company’s bipolar and schizophrenia treatment got a positive review in the wake of the
Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.
All rights reserved © 2024, Powered by Smart TechOne